NASDAQ:FTRE

Fortrea (FTRE) Stock Price, News & Analysis

$36.35
0.00 (0.00%)
(As of 04/26/2024 ET)
Today's Range
$36.13
$37.07
50-Day Range
$35.39
$40.28
52-Week Range
$24.92
$41.02
Volume
413,403 shs
Average Volume
751,729 shs
Market Capitalization
$3.25 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$37.29

Fortrea MarketRank™ Stock Analysis

Analyst Rating
Hold
2.38 Rating Score
Upside/​Downside
2.6% Upside
$37.29 Price Target
Short Interest
Bearish
5.22% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.11mentions of Fortrea in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
91.51%
From $1.06 to $2.03 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.39 out of 5 stars

Medical Sector

881st out of 913 stocks

Medical Laboratories Industry

18th out of 19 stocks

FTRE stock logo

About Fortrea Stock (NASDAQ:FTRE)

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

FTRE Stock Price History

FTRE Stock News Headlines

Reviewing Vyant Bio (OTCMKTS:VYNT) & Fortrea (NASDAQ:FTRE)
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
FTRE Mar 2024 22.500 put
FTRE Mar 2024 30.000 put
Key Takeaways From Fortrea Holdings Analyst Ratings
Fortrea Holdings Inc (K67.DU)
Fortrea Holdings Inc. (FTRE)
See More Headlines
Receive FTRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fortrea and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/11/2024
Today
4/27/2024
Next Earnings (Confirmed)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:FTRE
Fax
N/A
Employees
18,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$37.29
High Stock Price Target
$44.00
Low Stock Price Target
$27.00
Potential Upside/Downside
+2.6%
Consensus Rating
Hold
Rating Score (0-4)
2.38
Research Coverage
8 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.11 billion
Cash Flow
$2.43 per share
Book Value
$19.58 per share

Miscellaneous

Free Float
89,267,000
Market Cap
$3.25 billion
Optionable
Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

FTRE Stock Analysis - Frequently Asked Questions

Should I buy or sell Fortrea stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fortrea in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" FTRE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FTRE, but not buy additional shares or sell existing shares.
View FTRE analyst ratings
or view top-rated stocks.

What is Fortrea's stock price target for 2024?

8 equities research analysts have issued 12 month price targets for Fortrea's stock. Their FTRE share price targets range from $27.00 to $44.00. On average, they anticipate the company's stock price to reach $37.29 in the next year. This suggests a possible upside of 2.6% from the stock's current price.
View analysts price targets for FTRE
or view top-rated stocks among Wall Street analysts.

How have FTRE shares performed in 2024?

Fortrea's stock was trading at $34.90 at the beginning of the year. Since then, FTRE stock has increased by 4.2% and is now trading at $36.35.
View the best growth stocks for 2024 here
.

Are investors shorting Fortrea?

Fortrea saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 4,650,000 shares, a decrease of 12.4% from the March 15th total of 5,310,000 shares. Based on an average daily trading volume, of 885,900 shares, the days-to-cover ratio is currently 5.2 days. Approximately 5.2% of the company's shares are sold short.
View Fortrea's Short Interest
.

When is Fortrea's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our FTRE earnings forecast
.

How can I listen to Fortrea's earnings call?

Fortrea will be holding an earnings conference call on Tuesday, May 7th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Fortrea's earnings last quarter?

Fortrea Holdings Inc. (NASDAQ:FTRE) released its earnings results on Monday, March, 11th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.23 by $0.04. The business had revenue of $775.40 million for the quarter, compared to analysts' expectations of $779.09 million. The firm's revenue for the quarter was up 1.8% on a year-over-year basis.

What guidance has Fortrea issued on next quarter's earnings?

Fortrea updated its FY 2024 earnings guidance on Tuesday, March, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.1 billion-$3.2 billion, compared to the consensus revenue estimate of $3.2 billion.

Who are Fortrea's major shareholders?

Fortrea's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Penn Davis Mcfarland Inc. (0.64%), Raymond James & Associates (0.15%), New York State Teachers Retirement System (0.12%), Hedeker Wealth LLC (0.07%), State of Alaska Department of Revenue (0.06%) and Louisiana State Employees Retirement System (0.05%). Insiders that own company stock include Peter M Neupert and Thomas Pike.
View institutional ownership trends
.

How do I buy shares of Fortrea?

Shares of FTRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:FTRE) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners